Efficacy of a streptomycin-dependent, live Pasteurella haemolytica vaccine against challenge exposure to Pasteurella haemolytica in cattle
- PMID: 3296883
Efficacy of a streptomycin-dependent, live Pasteurella haemolytica vaccine against challenge exposure to Pasteurella haemolytica in cattle
Abstract
A streptomycin-dependent, live Pasteurella haemolytica vaccine was given in 1 or 2 doses to 2 groups of weaned calves; 2 other groups of calves were not vaccinated. All calves in the vaccinated groups and calves in 1 of the nonvaccinated groups were stressed by transport, intratracheally inoculated with bovine herpesvirus type-1 (Cooper strain), and then intratracheally inoculated with P haemolytica type A1. The 4th group of calves (nonvaccinated controls) was not stressed and were not intratracheally inoculated with virus or bacteria. Mean daily weight gains, total clinical sign scores, lung lesion scores, plasma fibrinogen concentrations, and antibody titers against P haemolytica were determined at various intervals. Calves that had been vaccinated twice had greater mean daily weight gains and lower total clinical sign scores and lung lesion scores than did nonvaccinated, challenge-exposed calves, but the difference was not significant (P greater than 0.05). Calves vaccinated once had the greatest mean daily weight gains, the lowest total clinical sign scores, and the lowest lung lesion scores when compared with the other 2 challenge-exposed groups of calves. Mean daily weight gains and total clinical sign scores of calves vaccinated once were significantly different (P less than 0.05) than those of calves vaccinated twice. Nonvaccinated, nonchallenge-exposed control calves did not develop clinical signs of disease, did not develop lung lesions, and had consistently positive daily weight gains, and had scores in these areas that were significantly different (P less than 0.05) from those of all challenge-exposed groups of calves. Increases in plasma fibrinogen concentrations corresponded to infection with P haemolytica.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effect of vaccination with live or killed Pasteurella haemolytica on resistance to experimental bovine pneumonic pasteurellosis.Am J Vet Res. 1985 Feb;46(2):342-7. Am J Vet Res. 1985. PMID: 3888006
-
Challenge exposure of cattle vaccinated with a chemically altered strain of Pasteurella haemolytica.Am J Vet Res. 1983 Oct;44(10):1848-52. Am J Vet Res. 1983. PMID: 6314851
-
Serum antibody response to carbohydrate antigens of Pasteurella haemolytica serotype 1: relation to experimentally induced bovine pneumonic pasteurellosis.Am J Vet Res. 1989 Jan;50(1):98-105. Am J Vet Res. 1989. PMID: 2465713
-
The evolution of vaccines for bovine pneumonic pasteurellosis.Res Vet Sci. 1989 Jul;47(1):1-10. Res Vet Sci. 1989. PMID: 2672200 Review.
-
Bovine pneumonic pasteurellosis: immunity to Pasteurella haemolytica.J Am Vet Med Assoc. 1988 Nov 15;193(10):1308-16. J Am Vet Med Assoc. 1988. PMID: 3060454 Review. No abstract available.
Cited by
-
Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE.Infect Immun. 2004 Dec;72(12):7265-74. doi: 10.1128/IAI.72.12.7265-7274.2004. Infect Immun. 2004. PMID: 15557652 Free PMC article.
-
Granulocyte plasma membrane damage by leukotoxic supernatant from Pasteurella haemolytica A1 and protection by immune serum.Can J Vet Res. 1990 Jan;54(1):146-50. Can J Vet Res. 1990. PMID: 2306664 Free PMC article.
-
Veterinary vaccines.Biotechnol Adv. 1994;12(3):489-523. doi: 10.1016/0734-9750(94)90021-3. Biotechnol Adv. 1994. PMID: 14548468 Free PMC article.
-
Three contiguous lipoprotein genes in Pasteurella haemolytica A1 which are homologous to a lipoprotein gene in Haemophilus influenzae type b.Infect Immun. 1993 Nov;61(11):4682-8. doi: 10.1128/iai.61.11.4682-4688.1993. Infect Immun. 1993. PMID: 8406866 Free PMC article.